Why the study?
Does self-management of anticoagulation improve control of anticoagulation and patient satisfaction in patients treated with vitamin K antagonists?
Does self-management of anticoagulation improve control of anticoagulation and patient satisfaction in patients treated with vitamin K antagonists?
Self-management of anticoagulation using portable coagulometers improves INR control and patient quality of life compared to standard care models.
Answers are grounded in this paper and cite their sources.
May enhance INR control and QoL via warfarin self-management; leaves open confirmation in contemporary RCTs.
Treatment with vitamin K antagonists (i.e., warfarin or coumadin derivatives) requires repeated monitoring of the intensity of anticoagulation and regular dose adjustment. Nevertheless, many patients are not in the therapeutic target range for a considerable proportion (30-50%) of the time. In addition, repeated laboratory checks and visits to the (anticoagulation) clinic or office are time-consuming and may have a negative impact on patient satisfaction. Recently, reliable portable coagulometers have become available and these devices allow the measurement of the international normalized ratio (INR) from a small drop of capillary blood, thereby enabling patients to self-manage their anticoagulation. Clinical studies show that self-testing of the INR and self-adjusting of the warfarin dose results in a better control of anticoagulation in comparison with regular care by general practitioners or specialists and is at least as good as management by a specialized anticoagulation clinic. Moreover, treatment-related patient satisfaction and quality of life improves in patients performing self-management of anticoagulation.
No takes yet. Share an insight, caveat, or question.
Marcel Levi (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: